These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9016333)

  • 1. Threonine6-bradykinin: molecular dynamics simulations in a biphasic membrane mimetic.
    Pellegrini M; Mierke DF
    J Med Chem; 1997 Jan; 40(1):99-104. PubMed ID: 9016333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threonine6-bradykinin: structural characterization in the presence of micelles by nuclear magnetic resonance and distance geometry.
    Pellegrini M; Mammi S; Peggion E; Mierke DF
    J Med Chem; 1997 Jan; 40(1):92-8. PubMed ID: 9016332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
    Otter A; Bigler P; Stewart JM; Kotovych G
    Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nmr and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lyso phosphatidylcholine micelles.
    Young JK; Hicks RP
    Biopolymers; 1994 May; 34(5):611-23. PubMed ID: 8003621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
    Sikorska Trzepałka E; Slusarz R; Lammek B
    J Biomol Struct Dyn; 2005 Oct; 23(2):125-34. PubMed ID: 16060686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
    Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
    J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for cis' proline with alpha-aminoisobutyric acid substitution. N.m.r. studies of AIB substituted bradykinins.
    London RE; Schmidt PG; Vavrek RJ; Stewart JM
    Int J Pept Protein Res; 1982 Apr; 19(4):334-42. PubMed ID: 7118404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the N-terminal beta-turn in bradykinin antagonists.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of bradykinin conformation in the presence of model membrane by Nuclear Magnetic Resonance and molecular modelling.
    Bonechi C; Ristori S; Martini G; Martini S; Rossi C
    Biochim Biophys Acta; 2009 Mar; 1788(3):708-16. PubMed ID: 19272336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and CD conformational studies of bradykinin and its agonists and antagonists: application to receptor binding.
    Kotovych G; Cann JR; Stewart JM; Yamamoto H
    Biochem Cell Biol; 1998; 76(2-3):257-66. PubMed ID: 9923694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aggregation properties of some bradykinin analogs.
    Liu X; Stewart JM; Cann JR; Gera L; Kotovych G
    J Biomol Struct Dyn; 1993 Aug; 11(1):169-79. PubMed ID: 8216942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR and simulated annealing investigations of bradykinin in presence of polyphenols.
    Richard T; Vergé S; Berké B; Vercauteren J; Monti JP
    J Biomol Struct Dyn; 2001 Feb; 18(4):627-37. PubMed ID: 11245257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-turns induced in bradykinin by (S)-alpha-methylproline.
    Welsh JH; Zerbe O; von Philipsborn W; Robinson JA
    FEBS Lett; 1992 Feb; 297(3):216-20. PubMed ID: 1544400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas-phase basicities for ions from bradykinin and its des-arginine analogues.
    Ewing NP; Pallante GA; Zhang X; Cassady CJ
    J Mass Spectrom; 2001 Aug; 36(8):875-81. PubMed ID: 11523086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of bradykinin in SDS micelles. Study using nuclear magnetic resonance, distance geometry, and restrained molecular mechanics and dynamics.
    Lee SC; Russell AF; Laidig WD
    Int J Pept Protein Res; 1990 May; 35(5):367-77. PubMed ID: 2165467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance studies of bradykinin antagonists.
    Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of bradykinin conformation in a dimethylsulfoxide solution by two-dimensional 1H-NMR spectroscopy].
    Saulitis IuB; Liepin'sh EE; Sekatsis IP; Mutulis FK; Chipens GI
    Bioorg Khim; 1986 Apr; 12(4):437-47. PubMed ID: 3718546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain.
    Ruan KH; Li D; Ji J; Lin YZ; Gao X
    Biochemistry; 1998 Jan; 37(3):822-30. PubMed ID: 9454571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
    Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
    J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.